Exoskeleton Partial-Coated Stem Cells for Infarcted Myocardium Restoring

被引:2
|
作者
He, Huihui [1 ]
Yuan, Yuan [2 ]
Wu, Yunhong [1 ]
Lu, Jingyi [1 ]
Yang, Xiaofu [1 ]
Lu, Kejie [1 ]
Liu, An [3 ]
Cao, Zelin [4 ]
Sun, Miao [1 ]
Yu, Mengfei [1 ]
Wang, Huiming [1 ]
机构
[1] Zhejiang Univ, Zhejiang Prov Clin Res Ctr Oral Dis, Engn Res Ctr Oral Biomat & Devices Zhejiang Prov, Sch Med,Stomatol Hosp,Sch Stomatol,Key Lab Oral Bi, Hangzhou 310000, Peoples R China
[2] Zhejiang Univ, Univ Edinburgh Inst, Key Lab Tissue Engn & Regenerat Med Zhejiang Prov, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthopaed Surg, Hangzhou 310009, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Clin Med Coll 1, Wenzhou 325035, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
cell partial encapsulation; exoskeletons; inorganic-organic nanobiohybrids; myocardial infarction; stem cells; STIMULI-RESPONSIVE NANOCARRIERS; CARDIAC ENGRAFTMENT; OXIDATIVE STRESS; IN-VIVO; ANGIOGENESIS; REGENERATION; THERAPY; REPAIR; TRANSPLANTATION; MECHANISMS;
D O I
10.1002/adma.202307169
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The integration of abiotic materials with live cells has emerged as an exciting strategy for the control of cellular functions. Exoskeletons consisting ofmetal-organic frameworks are generated to produce partial-coated bone marrow stem cells (BMSCs) to overcome low cell survival leading to disappointing effects for cell-based cardiac therapy. Partially coated exoskeletons can promote the survival of suspended BMSCs by integrating the support of exoskeletons and unimpaired cellular properties. In addition, partial exoskeletons exhibit protective effects against detrimental environmental conditions, including reactive oxygen species, pH changes, and osmotic pressure. The partial-coated cells exhibit increased intercellular adhesion forces to aggregate and adhere, promoting cell survival and preventing cell escape during cell therapy. The exoskeletons interact with cell surface receptors integrin alpha 5 beta 1, leading to augmented biological functions with profitable gene expression alteration, such as Vegfa, Cxcl12, and Adm. The partial-coated BMSCs display enhanced cell retention in infarcted myocardium through non-invasive intravenous injections. The repair of myocardial infarction has been achieved with improved cardiac function, myocardial angiogenesis, proliferation, and inhibition of cell apoptosis. This discovery advances the elucidation of potential molecular and cellular mechanisms for cell-exoskeleton interactions and benefits the rational design and manufacture of next-generation nanobiohybrids. Exoskeletons are generated to produce partial-coated bone marrow stem cells (BMSCs) as a novel biologic formulation with dual-sided characteristics. The exoskeleton side promotes cell viability and targeting, whereas the cell side retains the ability of cell adhesion and external secretion. With the synergism of increased survival, retention, and augmented paracrine secretion, the partial-coated BMSCs exhibit promising heart repair effects.image
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Stem cell repair of infarcted myocardium - An overview for clinicians
    Forrester, JS
    Price, MJ
    Makkar, RR
    CIRCULATION, 2003, 108 (09) : 1139 - 1145
  • [22] Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium
    Katritsis, D
    Sotiropoulou, P
    Karvouni, E
    Karabinos, I
    Korovesis, S
    Perez, S
    Voridis, E
    Papamichail, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 77A - 78A
  • [23] Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium
    Pasha, Zeeshan
    Wang, Yigang
    Sheikh, Riazuddin
    Zhang, Dongsheng
    Zhao, Tiemin
    Ashraf, Muhammad
    CARDIOVASCULAR RESEARCH, 2008, 77 (01) : 134 - 142
  • [24] Chemokine Contribution in Stem Cell Engraftment into the Infarcted Myocardium
    Liehn, Elisa A.
    Radu, Eugen
    Schuh, Alexander
    CURRENT STEM CELL RESEARCH & THERAPY, 2013, 8 (04) : 278 - 283
  • [25] Iron-oxide Labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium
    Amsalem, Yoram
    Mardor, Yael
    Feinberg, Micha S.
    Landa, Natalie
    Miller, Liron
    Daniels, Dianne
    Ocherashvilli, Aharon
    Holbova, Radka
    Yosef, Orna
    Barbash, Israel M.
    Leor, Jonathan
    CIRCULATION, 2007, 116 (11) : I38 - I45
  • [26] Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium
    Katritsis, DG
    Sotiropoulou, PA
    Karvouni, E
    Karabinos, I
    Korovesis, S
    Perez, SA
    Voridis, EM
    Papamichail, M
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 65 (03) : 321 - 329
  • [27] Mechanisms of mesenchymal stem cell homing to the infarcted myocardium
    Wu, YJ
    Ip, JE
    Zhang, LN
    Pratt, R
    Dzau, VJ
    CIRCULATION, 2004, 110 (17) : 172 - 172
  • [28] Transplanted bone marrow stem cells move to the infarcted myocardium and differentiate into smooth muscle cells and cardiomyocytes
    Fujita, J
    Suzuki, Y
    Ando, K
    Kawada, H
    Tomita, Y
    Kawaguchi, H
    Shibuya, I
    Yuasa, S
    Fukuda, K
    CIRCULATION, 2002, 106 (19) : 132 - 132
  • [29] Bone marrow cells regenerate infarcted myocardium
    Orlic, D
    Kajstura, J
    Chimenti, S
    Jakoniuk, I
    Anderson, SM
    Li, BS
    Pickel, J
    McKay, R
    Nadal-Ginard, B
    Bodine, DM
    Leri, A
    Anversa, P
    NATURE, 2001, 410 (6829) : 701 - 705
  • [30] Bone marrow cells regenerate infarcted myocardium
    Donald Orlic
    Jan Kajstura
    Stefano Chimenti
    Igor Jakoniuk
    Stacie M. Anderson
    Baosheng Li
    James Pickel
    Ronald McKay
    Bernardo Nadal-Ginard
    David M. Bodine
    Annarosa Leri
    Piero Anversa
    Nature, 2001, 410 : 701 - 705